BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30412141)

  • 1. Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis.
    Wang S; Chen Y; Chai Y
    Medicine (Baltimore); 2018 Oct; 97(43):e13018. PubMed ID: 30412141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Nov; 97(46):e13303. PubMed ID: 30431618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
    Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPX2 expression is associated with poor survival in gastric cancer.
    Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
    World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
    Jiang Y; Liu Y; Tan X; Yu S; Luo J
    Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.
    Wu D; Wu P; Zhao L; Huang L; Zhang Z; Zhao S; Huang J
    Medicine (Baltimore); 2015 Oct; 94(40):e1687. PubMed ID: 26448015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
    Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
    PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
    Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
    Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
    Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
    J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
    Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
    Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
    Wu P; Wu D; Li L; Chai Y; Huang J
    PLoS One; 2015; 10(6):e0131403. PubMed ID: 26114883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
    Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
    Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
    Xu M; Xu S
    Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.
    Yan L; Li S; Xu C; Zhao X; Hao B; Li H; Qiao B
    Tumour Biol; 2013 Dec; 34(6):4089-100. PubMed ID: 23873098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
    Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
    Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
    Shao T; Jiang X; Bao G; Li C; Guo C
    Dis Markers; 2022; 2022():7571066. PubMed ID: 36304254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
    Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
    Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
    Li L; Wu D; Yu Q; Li L; Wu P
    Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
    Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
    PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.